FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092000375> ?p ?o ?g. }

• W2092000375 endingPage "3078" @default.
• W2092000375 startingPage "3071" @default.
• W2092000375 abstract "Background— Monocyte activation is believed to play an important role in the pathogenesis of acute coronary syndromes (ACS). Neopterin is a soluble marker of monocyte activation, and elevated levels are of prognostic value in patients with stable coronary artery disease. Methods and Results— Neopterin levels were measured on average at 7 days (in 3946 patients) and at 4 months (in 3369 patients) after ACS in the PRavastatin Or atorVastatin Evaluation Infection Therapy–Thrombolysis In Myocardial Infarction (PROVE IT–TIMI 22) trial. We assessed the relationship between plasma neopterin levels and the risk of death and death or acute coronary events (nonfatal myocardial infarction or unstable angina) over 2 years. Seven days after an ACS event, neopterin levels ≥12.11 nmol/L (upper quartile, derived from a post hoc analysis) were associated with an increased risk of death and an increased risk of death or acute coronary events after adjustment for age, gender, history of diabetes mellitus, history of hypertension, history of smoking, type of ACS presentation, use of percutaneous coronary intervention for the index event, statin regimen, low-density lipoprotein cholesterol, and high-sensitivity C-reactive protein (hazard ratio, 1.86 [95% CI, 1.24 to 2.77], P =0.003; and hazard ratio, 1.33 [95% CI, 1.09 to 1.63] P =0.006, respectively). Neopterin levels ≥12.11 nmol/L at 4 months remained a predictor of death alone and of death or acute coronary events after multivariable adjustment that included adjustment for month 4 low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and statin regimen (hazard ratio, 2.39 [95% CI, 1.43 to 3.99], P =0.001; and hazard ratio, 1.60 [95% CI, 1.21 to 2.11], P =0.001). High-dose atorvastatin significantly attenuated the risk among subjects with neopterin levels ≥12.11 nmol/L at baseline (interaction P for death or acute coronary event, 0.018). Conclusions— Increased monocyte activation detected by an elevated plasma neopterin level identifies patients at long-term risk of death or recurrent acute coronary events after ACS. Intensive statin therapy significantly attenuates the risk of recurrent events among patients with an elevated neopterin level." @default.
• W2092000375 created "2016-06-24" @default.
• W2092000375 creator A5006206326 @default.
• W2092000375 creator A5024218470 @default.
• W2092000375 creator A5026602252 @default.
• W2092000375 creator A5030057930 @default.
• W2092000375 creator A5043533532 @default.
• W2092000375 creator A5058503662 @default.
• W2092000375 creator A5087487250 @default.
• W2092000375 date "2007-06-19" @default.
• W2092000375 modified "2023-10-04" @default.
• W2092000375 title "Long-Term Prognostic Value of Neopterin" @default.
• W2092000375 cites W1847805508 @default.
• W2092000375 cites W1967053946 @default.
• W2092000375 cites W1980087271 @default.
• W2092000375 cites W1983479740 @default.
• W2092000375 cites W1998953697 @default.
• W2092000375 cites W2002240714 @default.
• W2092000375 cites W2013371918 @default.
• W2092000375 cites W2026682916 @default.
• W2092000375 cites W2026759435 @default.
• W2092000375 cites W2026803942 @default.
• W2092000375 cites W2037289141 @default.
• W2092000375 cites W2042651340 @default.
• W2092000375 cites W2055888230 @default.
• W2092000375 cites W2056093579 @default.
• W2092000375 cites W2069378726 @default.
• W2092000375 cites W2094370941 @default.
• W2092000375 cites W2094941678 @default.
• W2092000375 cites W2096079570 @default.
• W2092000375 cites W2111926934 @default.
• W2092000375 cites W2118154631 @default.
• W2092000375 cites W2119475547 @default.
• W2092000375 cites W2121694529 @default.
• W2092000375 cites W2140008048 @default.
• W2092000375 cites W2142424111 @default.
• W2092000375 cites W2155191102 @default.
• W2092000375 cites W2159449551 @default.
• W2092000375 cites W2316376271 @default.
• W2092000375 cites W2324841714 @default.
• W2092000375 doi "https://doi.org/10.1161/circulationaha.106.666511" @default.
• W2092000375 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17548728" @default.
• W2092000375 hasPublicationYear "2007" @default.
• W2092000375 type Work @default.
• W2092000375 sameAs 2092000375 @default.
• W2092000375 citedByCount "130" @default.
• W2092000375 countsByYear W20920003752012 @default.
• W2092000375 countsByYear W20920003752013 @default.
• W2092000375 countsByYear W20920003752014 @default.
• W2092000375 countsByYear W20920003752015 @default.
• W2092000375 countsByYear W20920003752016 @default.
• W2092000375 countsByYear W20920003752017 @default.
• W2092000375 countsByYear W20920003752018 @default.
• W2092000375 countsByYear W20920003752019 @default.
• W2092000375 countsByYear W20920003752020 @default.
• W2092000375 countsByYear W20920003752021 @default.
• W2092000375 countsByYear W20920003752022 @default.
• W2092000375 countsByYear W20920003752023 @default.
• W2092000375 crossrefType "journal-article" @default.
• W2092000375 hasAuthorship W2092000375A5006206326 @default.
• W2092000375 hasAuthorship W2092000375A5024218470 @default.
• W2092000375 hasAuthorship W2092000375A5026602252 @default.
• W2092000375 hasAuthorship W2092000375A5030057930 @default.
• W2092000375 hasAuthorship W2092000375A5043533532 @default.
• W2092000375 hasAuthorship W2092000375A5058503662 @default.
• W2092000375 hasAuthorship W2092000375A5087487250 @default.
• W2092000375 hasBestOaLocation W20920003751 @default.
• W2092000375 hasConcept C126322002 @default.
• W2092000375 hasConcept C164705383 @default.
• W2092000375 hasConcept C207103383 @default.
• W2092000375 hasConcept C2776603314 @default.
• W2092000375 hasConcept C2777482532 @default.
• W2092000375 hasConcept C2777698277 @default.
• W2092000375 hasConcept C2777785093 @default.
• W2092000375 hasConcept C2777995511 @default.
• W2092000375 hasConcept C2780400711 @default.
• W2092000375 hasConcept C44249647 @default.
• W2092000375 hasConcept C500558357 @default.
• W2092000375 hasConcept C71924100 @default.
• W2092000375 hasConceptScore W2092000375C126322002 @default.
• W2092000375 hasConceptScore W2092000375C164705383 @default.
• W2092000375 hasConceptScore W2092000375C207103383 @default.
• W2092000375 hasConceptScore W2092000375C2776603314 @default.
• W2092000375 hasConceptScore W2092000375C2777482532 @default.
• W2092000375 hasConceptScore W2092000375C2777698277 @default.
• W2092000375 hasConceptScore W2092000375C2777785093 @default.
• W2092000375 hasConceptScore W2092000375C2777995511 @default.
• W2092000375 hasConceptScore W2092000375C2780400711 @default.
• W2092000375 hasConceptScore W2092000375C44249647 @default.
• W2092000375 hasConceptScore W2092000375C500558357 @default.
• W2092000375 hasConceptScore W2092000375C71924100 @default.
• W2092000375 hasIssue "24" @default.
• W2092000375 hasLocation W20920003751 @default.
• W2092000375 hasLocation W20920003752 @default.
• W2092000375 hasOpenAccess W2092000375 @default.
• W2092000375 hasPrimaryLocation W20920003751 @default.
• W2092000375 hasRelatedWork W2011576613 @default.
• W2092000375 hasRelatedWork W2100676360 @default.

• next